Detalhe da pesquisa
1.
Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe.
Adv Ther
; 41(1): 331-348, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957522
2.
Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping review.
Breast
; 57: 95-103, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33799233